Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Farudodstat

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ASLAN Receives Favorable Opinion on Patent Application for Farudodstat
    ASLAN Receives Favorable Opinion on Patent Application for Farudodstat

    29 Feb 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/02/29/2837813/0/en/ASLAN-Pharmaceuticals-Receives-Favorable-Opinion-From-the-European-Patent-Office-on-Composition-of-Matter-Patent-Application-for-Farudodstat.html

    GLOBENEWSWIRE
    29 Feb 2024
    Share Share
    ASLAN Announces Four Abstracts on Eblasakimab and Farudodstat
    ASLAN Announces Four Abstracts on Eblasakimab and Farudodstat

    24 Apr 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/04/24/2652547/0/en/ASLAN-Pharmaceuticals-Announces-Four-Abstracts-on-Eblasakimab-and-Farudodstat-Including-Two-Late-Breakers-to-be-Presented-at-the-1st-International-Societies-for-Investigative-Derma.html

    GLOBENEWSWIRE
    24 Apr 2023
    Share Share
    ASLAN to Host R&D Day on Novel DHODH Inhibitor Farudodstat
    ASLAN to Host R&D Day on Novel DHODH Inhibitor Farudodstat

    08 Mar 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/03/08/2622898/0/en/ASLAN-Pharmaceuticals-to-Host-Virtual-Research-and-Development-Day-on-Novel-DHODH-Inhibitor-Farudodstat-for-Alopecia-Areata.html

    GLOBENEWSWIRE
    08 Mar 2023
    Share Share